Chitooligosaccharides, which are oligosaccharides made up of b-1,4-linked D-glucosamine residues, have attracted much attention as new biomedical materials. Mixtures of chitooligosaccharides have been reported to have various biologic activities in vitro including antibacterial, 1, 2) antifungal, 3) antioxidant, 4, 5) antimutagenic, 6) and leukemia cell differentiation-inducing activities.
antioxidant, 4, 5) antimutagenic, 6) and leukemia cell differentiation-inducing activities. 7) The in vivo antioxidant activity of a mixture of chitooligosaccharides (3 kDaϽMWϽ5 kDa) was also reported. 8) Our recent study has revealed that chitobiose and chitotriose ( Fig. 1 ) showed higher antioxidant activities in vitro than other chitooligosaccharides in various assay systems. 9) The biologic activity in vivo and biologic availability of each chitooligosaccharide remain to be studied.
In the present study, we investigated the absorbability of several chitooligosaccharides from the rat gastrointestinal tract and also the pharmacokinetics of chitobiose and chitotriose administered intravenously or orally to rats.
MATERIALS AND METHODS

Materials
Wistar strain male rats (7 weeks old) were obtained from Clea Japan (Tokyo, Japan). The body weight of the rats at the time of usage ranged from 165 to 185 g. A series of chitooligosaccharides as hydrochlorides and a 4-aminobenzoyl ethyl ester (ABEE) labeling kit for the derivatization of chitooligosaccharides were purchased from Seikagaku Corp. (Tokyo, Japan). Based on HPLC analysis by the manufacturer, the purity of all chitooligosaccharides was approximately 100%.
Intravenous and Oral Administration Rats were fasted overnight (12 to 14 h) prior to experiments, but were allowed free access to water. Chitooligosaccharide solutions (1.0 ml/kg) in saline were administered intravenously through a tail vein or orally by gavage. Each rat was then left free in a metabolic cage for urine collection. Blood samples (about 150 ml) were taken with heparinized syringes from a tail vein at 0, 10, 20, 40, 60, 120, and 240 min postdosing and then immediately centrifuged to obtain plasma samples.
HPLC Analysis of Saccharides Saccharides in the plasma and urine were converted to fluorescent derivatives with an ABEE labeling kit as described by Yasuno et al. 10) Aliquots (40 ml) of the ABEE reagent solution were added to 10 ml of samples, and the mixtures were then incubated at 80°C for 1 h. After cooling to room temperature, 0.2 ml of distilled water and 0.2 ml of chloroform were added to the test tubes. The mixtures were vigorously vortexed and then centrifuged to separate them into two layers. Aliquots (10 ml) of the upper aqueous layer were used for HPLC analysis with a Honenpak C18 column (75ϫ4.6 mm, Seikagaku Corp.). Solvents A and B used for HPLC were 0.02% trifluoroacetic acid solutions containing 3% and 50% acetonitrile, respectively. Solvent A was passed through the column for 40 min for separation, and then the column was washed for 5 min with solvent B. Chromatography was performed at a flow rate of 1.0 ml/min and at a column temperature of 45°C. 
Pharmacokinetic Analysis
The area under the curve (AUC ) and the area under the first moment curve (AUMC ) for plasma chitobiose and chitotriose concentrations with respect to time from 0 until 4 h were calculated using the trapezoidal rule. The plasma concentration at time zero (C 0 ) and the first-order elimination rate constant (k el ) after intravenous administration were calculated from the y-intercept and slope of the regression line between ln C and time up to 2 h, respectively. The half-life (t 1/2 ) was calculated as ln 2/k el . The mean residence times after intravenous administration (MRT i.v. ) and oral administration (MRT p.o. ) were calculated by dividing the AUMC by AUC. The reciprocal of MRT was also used as an estimate of the elimination rate constant (k el ). The total body clearance (CL tot ) was calculated as the dose divided by AUC. The distribution volume (V d ) was calculated as the dose divided by C 0 . The absolute oral bioavailability (F) was estimated by comparing the AUC after intravenous administration and the AUC after oral administration. The mean absorption time (MAT ) was calculated by subtracting the MRT i.v. from MRT p.o. . The reciprocal of MAT was used as an estimate for the first-order absorption rate constant (k a ).
Statistical Analysis Results are expressed as meanϮ S.D. Statistical analysis was performed using the unpaired Student's t-test.
RESULTS
Analysis of Saccharides
A typical HPLC profile of ABEE-labeled saccharides is shown in Fig. 2 . The average retention times of glucosamine, chitobiose, chitotriose, chitotetraose, and chitopentaose were 35, 26, 16, 12, and 14 min, respectively. Calibration curves for the five sugars were all linear at least up to 200 mM; this concentration corresponds to 82 and 123 mg/ml for chitobiose and chitotriose, respectively. The detection limit for the five sugars was about 0.5 mM; this concentration corresponds to 0.21 and 0.31 mg/ml for chitobiose and chitotriose, respectively. Plasma samples containing a chitobiose or chitotriose concentration greater than 200 mM were analyzed after dilution with water to give sugar concentrations less than 200 mM.
Pharmacokinetic Analysis of Plasma Concentrations after Oral Administration Prior to the start of the pharmacokinetic analysis, we preliminarily examined whether chitobiose, chitotriose, chitotetraose, and chitopentaose would appear in rat plasma 1, 2, and 4 h after the oral administration of each saccharide at a dose of 300 mg/kg. Only the former two saccharides were detectable in the plasma at those times. Therefore we studied the pharmacokinetics only of chitobiose and chitotriose. Glucosamine was not detected in the plasma and urine of rats until at least 4 h after the oral administration of each of the four saccharides at a dose of 300 mg/kg and after the intravenous administration of chitobiose and chitotriose at a dose of 100 mg/kg.
The mean plasma concentration versus time curves of chitobiose and chitotriose after oral administration at doses of 30, 100, and 300 mg/kg are shown in Fig. 3 and the pharmacokinetic parameters are listed in Table 1 . The plasma concentrations of chitobiose and chitotriose were measurable even 10 min after oral administration at a dose of 30 mg/kg and reached their respective peaks around 1 h after administration. Chitotriose relative to chitobiose attained a higher maximum plasma concentration when given at a dose of 300 mg/kg. When given at doses of 30 and 100 mg/kg, however, the maximum plasma concentrations of chitobiose were higher than those of chitotriose. The oral bioavailability of chitobiose was higher than that of chitotriose at all doses examined.
Pharmacokinetic Analysis of Plasma Concentrations after Intravenous Administration
The mean plasma concentration versus time curves of chitobiose and chitotriose after intravenous administration to rats at a dose of 100 mg/kg are shown in Fig. 4 . A liner relationship between ln C and time was observed, suggesting that chitobiose and chitotriose were eliminated from the body following a onecompartment model. Selected relevant pharmacokinetic para- 546 Vol. 28, No. 3
Fig. 2. Separation of ABEE-Labeled Saccharides Using HPLC
A mixture of saccharides was added to rat plasma to give a 10-mM concentration of each saccharide, derivatized with ABEE, and then analyzed using HPLC. meters are listed in Table 2 .
The plasma concentration of chitotriose was significantly higher than that of chitobiose as revealed by the greater AUC and lower CL tot . The V d of chitobiose was higher than that of chitotriose.
DISCUSSION
To the best of our knowledge, this is the first study demonstrating that chitobiose and chitotriose when given orally are absorbed from the gastrointestinal tract, whereas chitotetraose and chitopentaose are not. Our results indicate that when a mixture of chitooligosaccharides is orally administered, only those of low molecular weight, i.e., chitobiose and chitotriose, can enter the circulatory system to exert their biologic effects. Chitobiose and chitotriose effectively protected rats from hepatic injury induced by carbon tetrachloride when given orally at a dose of 100 mg/kg/day (Chen A. S., Taguchi T., Sakai K., Miwa I., unpublished observation). This is consistent with the present result that chitobiose and chitotriose can enter the circulatory system when given orally.
The urinary recoveries of both chitobiose and chitotriose, estimated as the percentage of the amount of saccharide in 48-h urine with respect to the product of the F 0-4 value and the amount of saccharide administered, were more than 90% after oral administration of 100 mg/kg (data not shown). We also found that glucosamine, a possible hydrolysis product of chitobiose and chitotriose, was absent in the plasma and urine of rats at least until 4 h after their oral or intravenous administration. Taken together, these findings indicate that both saccharides are nearly not metabolized when given orally to rats.
Assuming that the drug elimination follows a one-compartment model, the reciprocal of MRT i.v. should be an estimate of k el . As seen in Table 2 , k el estimated based on MRT i.v. agreed well with that calculated from the slope of the regression line drawn in Fig. 4 . The relatively small distribution volume and short half-life of chitobiose and chitotriose (Table 2) implies that both saccharides are eliminated from the blood quickly.
The absorption rate constant estimated as the reciprocal of MAT was less than 1.0 h Ϫ1 (Table 1 ) and smaller than the elimination rate constants (2.2Ϯ0.3 h Ϫ1 for chitobiose and 2.7Ϯ0.1 h Ϫ1 for chitotriose; Table 2 ). The slope of a regression line between ln C and time calculated using the last three points for chitotriose 300 mg/kg in Fig. 3 was 0.95Ϯ0.21 h Ϫ1 which was very close to k a (0.93Ϯ0.10 h Ϫ1 ) for chitotriose 300 mg/kg. The slopes calculated using the last three points for 30 and 100 mg/kg chitotriose in Fig. 3 were also less than 1.0 h
Ϫ1
, although their agreement with corresponding k a values was not as good as for chitotriose 300 mg/kg. The reason why the slope for chitotriose 300 mg/kg was in good agreement with k a may be that the plasma concentrations were far higher than the quantification limit of chitotriose to allow us to calculate the slope with small error. These results suggest that the absorption of chitobiose and chitotriose is slow, resulting in flip-flop kinetics.
